Redeveloping Old Antibiotics for Use: European Initiative-Ursula Theuretzbacher, Ph.D.-10/06/2015 - 8:30am

Event Information
Event Topic: 
Redeveloping Old Antibiotics for Use: European Initiative
Event Date: 
10/06/2015 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Ursula Theuretzbacher, Ph.D.
Event Speaker Title: 
Founder and Principal
Event Speaker Company: 
Center for Anti-Infective Agents
Event Speaker Bio: 


Dr. Ursula Theuretzbacher

Dr. Ursula Theuretzbacher is founder and principal of the Center for Anti-Infective Agents in Vienna, Austria, since 1988. A microbiologist by training, she dedicated her professional life to antibacterial and antifungal drug R&D as well as appropriate and optimized usage of these drugs. She focuses on resistance and dosing issues from the early development phase to the use of old and new drugs in clinical practice.
Dr. Theuretzbacher is currently “work package leader” in the multinational collaborative EU-funded project AIDA (Re-developing old antibiotics) and in the multinational public-private partnership project DRIVE-AB (Incentivizing antibacterial drug R&D, funded by the EU Innovative Medicines Initiative=IMI) and partner in the IMI project COMBACTE-MAGNET (Developing new molecules against Gram-Negative Infections). Dr. Theuretzbacher is currently President of the Society of Anti‐Infective Pharmacology (ISAP) and Past and Founding President of the ESCMID (European Society of Clinical Microbiology and Infectious Diseases) PK/PD of Anti‐Infectives Study Group (EPASG). She is chair of a policy and scientific study group of the International Society of Chemotherapy (ISC), Council Member of the International Society of Infectious Diseases (ISID) and member of the ECCMID Programme Committee. She has published widely read text books on clinical microbiology and authored and/or co-authored reviews, book chapters, research papers on resistance, PK/PD, and antibacterial and antifungal agents.

Event Details
Cost: 
$0
Event Details: 

Dr. Theureztbacher will talk about the interesting initiative in Europe to overcome critical shortage worldwide of effective antibiotics due to the development of resistance to modern antibiotic drugs resulting from medical misuse and overuse as well as other market place practices. The Initiative includes the multinational collaborative EU-funded project AIDA (Re-developing old antibiotics) and the multinational public-private partnership project DRIVE-AB (Incentivizing antibacterial drug R&D, funded by the EU Innovative Medicines Initiative=IMI).